A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Obesity

Treatments: Drug: MK0557

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092872

2004_031

MK0557-012

0557-012

Details and patient eligibility

About

This is a 1-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients after a very low calorie diet.

Enrollment: 359 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Obese men and nonpregnant women between the ages of 18 and 65 years with a body mass index (height to weight ratio) as required by the study.

Exclusion criteria

• Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind